Tags : Iron

Rockwell’s Triferic AVNU Receives the US FDA’s Approval to Replace

Shots: The approval is based on the study assessing Triferic in adult patients with hemodialysis-dependent chronic kidney disease and has resulted in steady and consistent bioavailable iron to replace the iron that is lost at every dialysis treatment and hemoglobin is maintained The company will launch Evaluation Programs for evaluating Triferic and with expected launch […]Read More